Table of Content

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Bioanalytical Services Market

4. Market Overview
4.1. Introduction
4.1.1. Services Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Bioanalytical Services Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights
5.1. Key Industry Events (mergers, acquisitions, partnerships, etc.)
5.2. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
5.3. Technological Advancements

6. Global Bioanalytical Services Market Analysis and Forecast, by Service
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Services, 2017–2031
6.3.1. Immunochemistry Service
6.3.2. Quantitative Immunoassays
6.3.3. Cell-Based Neutralization Assays
6.3.4. LCMS Method Development
6.3.5. Discovery Phase Bioanalysis
6.3.6. LCMS Sample Bioanalysis
6.3.7. GCP Bioanalysis Service
6.3.8. Biomarker Assays
6.3.9. Protein Analysis
6.3.10. Others
6.4. Market Attractiveness By Service

7. Global Bioanalytical Services Market Analysis and Forecast, by Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Type, 2017–2031
7.3.1. Small Molecule Bioanalysis
7.3.2. Large Molecule Bioanalysis
7.3.3. Others
7.4. Market Attractiveness Analysis, by Type

8. Global Bioanalytical Services Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Pharma & Biotechnology Companies
8.3.2. Contract Research Organizations
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user

9. Global Bioanalytical Services Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Country/Region

10. North America Bioanalytical Services Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Service, 2017–2031
10.2.1. Immunochemistry Service
10.2.2. Quantitative Immunoassays
10.2.3. Cell-Based Neutralization Assays
10.2.4. LCMS Method Development
10.2.5. Discovery Phase Bioanalysis
10.2.6. LCMS Sample Bioanalysis
10.2.7. GCP Bioanalysis Service
10.2.8. Biomarker Assays
10.2.9. Protein Analysis
10.2.10. Others
10.3. Market Value Forecast, by Type, 2017–2031
10.3.1. Small Molecule Bioanalysis
10.3.2. Large Molecule Bioanalysis
10.3.3. Others
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Pharma & Biotechnology Companies
10.4.2. Contract Research Organizations
10.4.3. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Service
10.6.2. By Type
10.6.3. By End-user
10.6.4. By Country

11. Europe Bioanalytical Services Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Service, 2017–2031
11.2.1. Immunochemistry Service
11.2.2. Quantitative Immunoassays
11.2.3. Cell-Based Neutralization Assays
11.2.4. LCMS Method Development
11.2.5. Discovery Phase Bioanalysis
11.2.6. LCMS Sample Bioanalysis
11.2.7. GCP Bioanalysis Service
11.2.8. Biomarker Assays
11.2.9. Protein Analysis
11.2.10. Others
11.3. Market Value Forecast, by Type, 2017–2031
11.3.1. Small Molecule Bioanalysis
11.3.2. Large Molecule Bioanalysis
11.3.3. Others
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Pharma & Biotechnology Companies
11.4.2. Contract Research Organizations
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. U.K.
11.5.2. Germany
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Service
11.6.2. By Type
11.6.3. By End-user
11.6.4. By Country/Sub-region

12. Asia Pacific Bioanalytical Services Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Service, 2017–2031
12.2.1. Immunochemistry Service
12.2.2. Quantitative Immunoassays
12.2.3. Cell-Based Neutralization Assays
12.2.4. LCMS Method Development
12.2.5. Discovery Phase Bioanalysis
12.2.6. LCMS Sample Bioanalysis
12.2.7. GCP Bioanalysis Service
12.2.8. Biomarker Assays
12.2.9. Protein Analysis
12.2.10. Others
12.3. Market Value Forecast, by Type, 2017–2031
12.3.1. Small Molecule Bioanalysis
12.3.2. Large Molecule Bioanalysis
12.3.3. Others
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Pharma & Biotechnology Companies
12.4.2. Contract Research Organizations
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Service
12.6.2. By Type
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Bioanalytical Services Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Service, 2017–2031
13.2.1. Immunochemistry Service
13.2.2. Quantitative Immunoassays
13.2.3. Cell-Based Neutralization Assays
13.2.4. LCMS Method Development
13.2.5. Discovery Phase Bioanalysis
13.2.6. LCMS Sample Bioanalysis
13.2.7. GCP Bioanalysis Service
13.2.8. Biomarker Assays
13.2.9. Protein Analysis
13.2.10. Others
13.3. Market Value Forecast, by Type, 2017–2031
13.3.1. Small Molecule Bioanalysis
13.3.2. Large Molecule Bioanalysis
13.3.3. Others
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Pharma & Biotechnology Companies
13.4.2. Contract Research Organizations
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Service
13.6.2. By Type
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Bioanalytical Services Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Service, 2017–2031
14.2.1. Immunochemistry Service
14.2.2. Quantitative Immunoassays
14.2.3. Cell-Based Neutralization Assays
14.2.4. LCMS Method Development
14.2.5. Discovery Phase Bioanalysis
14.2.6. LCMS Sample Bioanalysis
14.2.7. GCP Bioanalysis Service
14.2.8. Biomarker Assays
14.2.9. Protein Analysis
14.2.10. Others
14.3. Market Value Forecast, by Type, 2017–2031
14.3.1. Small Molecule Bioanalysis
14.3.2. Large Molecule Bioanalysis
14.3.3. Others
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Pharma & Biotechnology Companies
14.4.2. Contract Research Organizations
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Service
14.6.2. By Type
14.6.3. By End-user
14.6.4. By Country/Sub-region

15. Competition Landscape
15.1. Market Player - Competition Matrix
15.2. Market Share Analysis, by Company, 2020
15.3. Competitive Business Strategies
15.4. Company Profiles
15.4.1. PPD, Inc.
15.4.1.1. Company Description
15.4.1.2. Business Overview
15.4.1.3. Financial Overview
15.4.1.4. SWOT Analysis
15.4.2. ICON plc
15.4.2.1. Company Description
15.4.2.2. Business Overview
15.4.2.3. Financial Overview
15.4.2.4. SWOT Analysis
15.4.3. Laboratory Corporation of America
15.4.3.1. Company Description
15.4.3.2. Business Overview
15.4.3.3. Financial Overview
15.4.3.4. SWOT Analysis
15.4.4. Charles River Laboratories International, Inc.
15.4.4.1. Company Description
15.4.4.2. Business Overview
15.4.4.3. Financial Overview
15.4.4.4. SWOT Analysis
15.4.5. Syneos Health
15.4.5.1. Company Description
15.4.5.2. Business Overview
15.4.5.3. Financial Overview
15.4.5.4. SWOT Analysis
15.4.6. SGS SA
15.4.6.1. Company Description
15.4.6.2. Business Overview
15.4.6.3. SWOT Analysis
15.4.7. Toxikon, Inc.
15.4.7.1. Company Description
15.4.7.2. Business Overview
15.4.7.3. SWOT Analysis
15.4.8. Intertek Group
15.4.8.1. Company Description
15.4.8.2. Business Overview
15.4.8.3. Financial Overview
15.4.8.4. SWOT Analysis
15.4.9. Pace Analytical Services
15.4.9.1. Company Description
15.4.9.2. Business Overview
15.4.9.3. SWOT Analysis
15.4.10. Medpace
15.4.10.1. Company Description
15.4.10.2. Business Overview
15.4.10.3. Financial Overview
15.4.10.4. SWOT Analysis
15.4.11. PRA HEALTH SCIENCES
15.4.11.1. Company Description
15.4.11.2. Business Overview
15.4.11.3. Financial Overview
15.4.11.4. SWOT Analysis
15.4.12. WuXi AppTec
15.4.12.1. Company Description
15.4.12.2. Business Overview
15.4.12.3. Financial Overview
15.4.12.4. SWOT Analysis
15.4.13. IQVIA
15.4.13.1. Company Description
15.4.13.2. Business Overview
15.4.13.3. Financial Overview
15.4.13.4. SWOT Analysis
15.4.14. Eurofins Scientific
15.4.14.1. Company Description
15.4.14.2. Business Overview
15.4.14.3. Financial Overview
15.4.14.4. SWOT Analysis



List of Figures

List of Figures

Figure 01: Global Bioanalytical Services Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Bioanalytical Services Market Value Share, by Type, 2020

Figure 03: Global Bioanalytical Services Market Value Share, by Region, 2020

Figure 04: Global Bioanalytical Services Market Value Share, by Service, 2020

Figure 05: Global Bioanalytical Services Market Value Share, by End-user, 2020

Figure 06: Global Bioanalytical Services Market Attractiveness Analysis, by Service, 2021–2031

Figure 07: Global Bioanalytical Services Market Value Share Analysis, by Service, 2020 and 2031

Figure 08: Global Bioanalytical Services Market Revenue (US$ Mn), by Immunochemistry Services, 2017–2031

Figure 09: Global Bioanalytical Services Market Revenue (US$ Mn), by Quantitative Immunoassays, 2017–2031

Figure 10: Global Bioanalytical Services Market Revenue (US$ Mn), by Cell-Based Neutralization Assays, 2017–2031

Figure 11: Global Bioanalytical Services Market Revenue (US$ Mn), by LCMS Method Development, 2017–2031

Figure 12: Global Bioanalytical Services Market Revenue (US$ Mn), by Discovery Phase Bioanalysis, 2017–2031

Figure 13: Global Bioanalytical Services Market Revenue (US$ Mn), by LCMS Sample Bioanalysis, 2017–2031

Figure 14: Global Bioanalytical Services Market Revenue (US$ Mn), by GCP Bioanalysis Service, 2017–2031

Figure 15: Global Bioanalytical Services Market Revenue (US$ Mn), by Biomarker Assays, 2017–2031

Figure 16: Global Bioanalytical Services Market Revenue (US$ Mn), by Protein Analysis, 2017–2031

Figure 17: Global Bioanalytical Services Market Revenue (US$ Mn), by Others, 2017–2031

Figure 18: Global Bioanalytical Services Market Value Share Analysis, by Type, 2020 and 2031

Figure 19: Global Bioanalytical Services Market Attractiveness Analysis, by Type, 2021–2031

Figure 20: Global Bioanalytical Services Market Revenue (US$ Mn), by Small Molecule Bioanalysis, 2017–2031

Figure 21: Global Bioanalytical Services Market Revenue (US$ Mn), by Large Molecule Bioanalysis, 2017–2031

Figure 22: Global Bioanalytical Services Market Revenue (US$ Mn), by Others, 2017–2031

Figure 23: Global Bioanalytical Services Market Value Share Analysis, by End-user, 2020 and 2031

Figure 24: Global Bioanalytical Services Market Attractiveness Analysis, by End-user, 2021–2031

Figure 25: Global Bioanalytical Services Market Value (US$ Mn), by Pharma & Biotechnology Companies, 2017–2031

Figure 26: Global Bioanalytical Services Market Value (US$ Mn), by Contract Research Organizations, 2017–2031

Figure 27: Global Bioanalytical Services Market Revenue (US$ Mn), by Others, 2017–2031

Figure 28: Global Bioanalytical Services Market Value Share Analysis, by Region, 2020 and 2031

Figure 29: Global Bioanalytical Services Market Attractiveness Analysis, by Region, 2021–2031

Figure 30: North America Bioanalytical Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 31: North America Bioanalytical Services Market Value Share, by Country, 2020–2031

Figure 32: North America Bioanalytical Services Market Attractiveness Analysis, by Country, 2021–2031

Figure 33: North America Bioanalytical Services Market Value Share Analysis, by Service, 2020 and 2031

Figure 34: North America Bioanalytical Services Market Attractiveness Analysis, by Service, 2021–2031

Figure 35: North America Bioanalytical Services Market Value Share Analysis, by Type, 2020 and 2031

Figure 36: North America Bioanalytical Services Market Attractiveness Analysis, by Type, 2021–2031

Figure 37: North America Bioanalytical Services Market Value Share Analysis, by End-user, 2020 and 2031

Figure 38: North America Bioanalytical Services Market Attractiveness Analysis, by End-user, 2021–2031

Figure 39: Europe Bioanalytical Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 40: Europe Bioanalytical Services Market Value Share (%), by Country/Sub-region, 2020 and 2031

Figure 41: Europe Bioanalytical Services Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 42: Europe Bioanalytical Services Market Value Share Analysis, by Service, 2020 and 2031

Figure 43: Europe Bioanalytical Services Market Attractiveness Analysis, by Service, 2021–2031

Figure 44: Europe Bioanalytical Services Market Value Share Analysis, by Type, 2020 and 2031

Figure 45: Europe Bioanalytical Services Market Attractiveness Analysis, by Type, 2021–2031

Figure 46: Europe Bioanalytical Services Market Value Share Analysis, by End-user, 2020 and 2031

Figure 47: Europe Bioanalytical Services Market Attractiveness Analysis, by End-user, 2021–2031

Figure 48: Asia Pacific Bioanalytical Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 49: Asia Pacific Bioanalytical Services Market Value Share (%), by Country/Sub-region, 2020 and 2031

Figure 50: Asia Pacific Bioanalytical Services Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 51: Asia Pacific Bioanalytical Services Market Value Share Analysis, by Service, 2020 and 2031

Figure 52: Asia Pacific Bioanalytical Services Market Attractiveness Analysis, by Service, 2021–2031

Figure 53: Asia Pacific Bioanalytical Services Market Value Share Analysis, by Type, 2020 and 2031

Figure 54: Asia Pacific Bioanalytical Services Market Attractiveness Analysis, by Type, 2021–2031

Figure 55: Asia Pacific Bioanalytical Services Market Value Share Analysis, by End-user, 2020 and 2031

Figure 56: Asia Pacific Bioanalytical Services Market Attractiveness Analysis, by End-user, 2021–2031

Figure 57: Latin America Bioanalytical Services Market Value (US$ Mn) Forecast, 2017–2031

Figure 58: Latin America Bioanalytical Services Market Value Share, by Country/Sub-region, 2020–2031

Figure 59: Latin America Bioanalytical Services Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 60: Latin America Bioanalytical Services Market Value Share Analysis, by Service, 2020 and 2031

Figure 61: Latin America Bioanalytical Services Market Attractiveness Analysis, by Service, 2021–2031

Figure 62: Latin America Bioanalytical Services Market Value Share Analysis, by Type, 2020 and 2031

Figure 63: Latin America Bioanalytical Services Market Attractiveness Analysis, by Type, 2021–2031

Figure 64: Latin America Bioanalytical Services Market Value Share Analysis, by End-user, 2020 and 2031

Figure 65: Latin America Bioanalytical Services Market Attractiveness Analysis, by End-user, 2021–2031

Figure 66: Middle East & Africa Bioanalytical Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 67: Middle East & Africa Bioanalytical Services Market Value Share, by Country/Sub-region, 2020–2031

Figure 68: Middle East & Africa Bioanalytical Services Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 69: Middle East & Africa Bioanalytical Services Market Value Share Analysis, by Service, 2020 and 2031

Figure 70: Middle East & Africa Bioanalytical Services Market Attractiveness Analysis, by Service, 2021–2031

Figure 71: Middle East & Africa Bioanalytical Services Market Value Share Analysis, by Type, 2020 and 2031

Figure 72: Middle East & Africa Bioanalytical Services Market Attractiveness Analysis, by Type, 2021–2031

Figure 73: Middle East & Africa Bioanalytical Services Market Value Share Analysis, by End-user, 2020 and 2031

Figure 74: Middle East & Africa Bioanalytical Services Market Attractiveness Analysis, by End-user, 2021–2031

List of Tables

List of Tables

Table 01: Global Bioanalytical Services Market Value (US$ Mn) Forecast, by Service, 2017–2031

Table 02: Global Bioanalytical Services Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 03: Global Bioanalytical Services Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 04: Global Bioanalytical Services Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 05: North America Bioanalytical Services Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 06: North America Bioanalytical Services Market Value (US$ Mn) Forecast, by Service, 2017–2031

Table 07: North America Bioanalytical Services Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 08: North America Bioanalytical Services Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 09: Europe Bioanalytical Services Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 10: Europe Bioanalytical Services Market Value (US$ Mn) Forecast, by Service, 2017–2031

Table 11: Europe Bioanalytical Services Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 12: Europe Bioanalytical Services Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 13: Asia Pacific Bioanalytical Services Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Asia Pacific Bioanalytical Services Market Value (US$ Mn) Forecast, by Service, 2017–2031

Table 15: Asia Pacific Bioanalytical Services Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 16: Asia Pacific Bioanalytical Services Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 17: Latin America Bioanalytical Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 18: Latin America Bioanalytical Services Market Value (US$ Mn) Forecast, by Service, 2017–2031

Table 19: Latin America Bioanalytical Services Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 20: Latin America Bioanalytical Services Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 21: Middle East & Africa Bioanalytical Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 22: Middle East & Africa Bioanalytical Services Market Value (US$ Mn) Forecast, by Service, 2017–2031

Table 23: Middle East & Africa Bioanalytical Services Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 24: Middle East & Africa Bioanalytical Services Market Value (US$ Mn) Forecast, by End-user, 2017–2031